[Federal Register Volume 70, Number 73 (Monday, April 18, 2005)]
[Notices]
[Page 20113]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-7608]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Prophylactic and 
Therapeutic Monoclonal Antibodies

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Patent Application No. 
10/987,533 entitled ``Prophylactic and Therapeutic Monoclonal 
Antibodies,'' filed November 12, 2004. Foreign rights are also 
available (PCT/US04/38480). The United States Government, as 
represented by the Secretary of the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA-J, 504 Scott Street, Fort 
Detrick, Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: In this application are described monoclonal 
antibodies which specifically recognize V antigen of Y pestis and 
epitopes recognized by these monoclonal antibodies. Also provided are 
mixtures of antibodies of the present invention, as well as methods of 
using individual antibodies or mixtures thereof for the detection, 
prevention, and/or therapeutical treatment of plague infections in 
vitro and in vivo.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 05-7608 Filed 4-15-05; 8:45 am]
BILLING CODE 3710-08-M